Keyword: Pharmaceuticals

News

GSK Invites Private Equity Bids for Older Drugs

01.06.2014 - UK pharmaceutical producer GlaxoSmithKline has invited private equity firms to consider making offers for a range of its older drugs, news agencies report, citing people familiar...

News

US Court Dismisses Teva Case to Block Generic Copaxone

16.05.2014 - Shortly before expiration of the patent on the multiple sclerosis treatment Copaxone, a US district court has dismissed a case by Teva Pharmaceutical Industries, subsidiary of the...

Strategy & Management

Maximum Return on Surplus and idle assets

09.05.2014 - Surplus and idle assets - Throughout industry, pressure to squeeze maximum return from each and every asset is intense. This principle drives process simplification and the focus...

News

UK Prime Minister Calls on Pfizer for More Guarantees

08.05.2014 - British prime minister David Cameron has called on U.S. drugmaker Pfizer to give stronger guarantees it will keep jobs and investment in the UK if it is to secure his government's...

Strategy & Management

International Drugmakers Meet Challenges

08.05.2014 - In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...

News

UK May Use Public Interest Against Pfizer’s AstraZeneca Bid

07.05.2014 - The UK could use its public interest powers to intervene in U.S. drugmaker Pfizer's potential takeover of British pharmaceutical firm AstraZeneca, Business Secretary Vince Cable...

News

Pfizer Ups Offer for AstraZeneca to $106 Billion

05.05.2014 - U.S. drugmaker Pfizer increased its offer for the UK's AstraZeneca on May 2 to £63 billion ($106 billion) but the proposal, which would create the world's biggest pharmaceuticals...

News

Merck Consumer Unit Said to be Worth $14 Billion for Bayer

05.05.2014 - With UK consumer health giant Reckitt having bowed out of the race to acquire the consumer business of U.S. drugmaker Merck & Co, Germany's Bayer is said to be in exclusive...